AlphAIAlphAI — Financial news for AI agents
SEC EDGAR$TRNS

IRICK JAIME A purchased $230K of TRNS

IRICK JAIME A (President and CEO) purchased 2,275 shares of TRANSCAT INC (TRNS) at $101.26 ($0.23M total) on 2026-11-05.

Original reporting
SEC EDGAR · IRICK JAIME A
Published Nov 6, 2026, 9:30 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Nov 6, 2026, 9:33 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About AlphAI AI DeskScoring methodologyReport an issue
AlphAI market briefInsider activity
Primary signal
$TRNS
Neutral
medium confidence
Mentioned
$TRNS
Relevance
5/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$TRNSNeutralLow
01

Why it matters

The insider buy is modest and unlikely to move the stock significantly, but it adds a data point for monitoring executive confidence.

02

Market read

A small insider purchase with limited immediate trading relevance.

03

What to watch

Potential upcoming corporate actions or financing needs not disclosed.

Relevance 5/10Novelty 4/10Timing: today

Background

Form 4 filings disclose insider transactions and are primary sources for such events.

Company-level read

Ticker impact

$TRNSNeutralMedium confidence
Context

CEO Irick Jaime A bought 2,275 shares of Transcat Inc for $230,366.50 in a Form 4 filing.

Expected impact

slight upward pressure as market absorbs insider buying

Evidence & confidence

The purchase is under $1M and represents a tiny fraction of float, limiting material impact.

Market effects

Sector

Minimal effect on the industrial equipment sector.

Regional

No broader regional impact.

Global

Not globally relevant.

Counterpoint

What could challenge this read

The purchase could be a routine portfolio rebalancing rather than a strong endorsement.

Key entities

  • Person
    Irick Jaime A

    President and CEO of Transcat Inc.

  • Company
    Transcat Inc

    Manufacturer of industrial equipment, ticker TRNS.

Read at source← All news

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

TRNS insider trading history →

Related articles

$TRNSMedAI 8/10

Transcat (TRNS) Q2 2027 Earnings Call Transcript

Transcat (TRNS) reported Q2 2027 revenue of $97.1M, up 18%, with service revenue growing 23% and distribution revenue up 10%. Gross profit increased 22%, and adjusted EBITDA grew 23% to $14.9M. The company cited strong demand in regulated end markets and strategic acquisitions, including Southeastern Biomedical Associates, as drivers of growth. Service gross margins expanded 220 basis points to 34.4%.

finance.yahoo.com
$TRNSMed

Transcat Q2 Earnings Call Highlights

Transcat (TRNS) reported Q2 growth in distribution revenue (10% to $32.3M) and adjusted EBITDA (23% to $14.9M). Management raised its fiscal 2027 service organic revenue growth outlook to low-double-digits and expects service gross-margin expansion. The company highlighted demand in regulated markets and completed an acquisition to expand its biomedical calibration footprint.

finance.yahoo.com
$TRNSMed

Transcat Reports Strong Fiscal Second Quarter 2027 Financial Results with Double-Digit Service Organic Revenue* Growth and Significant Service Gross Margin…

TRANSCAT INC (TRNS) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 NEWS RELEASE Transcat, Inc. 35 Vantage Point Drive • Rochester • NY • 14624 • Phone: (585) 352-7777 Transcat Reports Strong Fiscal Second Quarter 2027 Financial Results with Double-Digit Service Organic Revenue* Growth and Significant Service Gross Margin Expansion •

SEC EDGAR 8-K